Filing Details
- Accession Number:
- 0001274644-16-000101
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-07 08:08:15
- Reporting Period:
- 2016-03-04
- Filing Date:
- 2016-03-07
- Accepted Time:
- 2016-03-07 08:08:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1274644 | Ocera Therapeutics Inc. | OCRX | Pharmaceutical Preparations (2834) | 631192270 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1413306 | S Linda Grais | C/O Ocera Therapeutics, Inc. 525 University Avenue, Suite 610 Palo Alto CA 94301 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-03-04 | 3,000 | $3.19 | 63,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents the weighted average price for the shares. The shares were purchased at prices ranging from $3.11 per share to $3.24 per share.
- The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.